Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 10, 2012, Pages 1749-1753

  Camós, Silvia ^a   Cruz, M Jesús ^a,b   Morell, Ferran ^a,b   Solé, Esther ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

ACE activity; Angiotensin converting enzyme (ACE); Genetic based reference values

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ENZYME ACTIVITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; SARCOIDOSIS; SPAIN;

ADULT; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; REFERENCE VALUES; SPAIN; YOUNG ADULT;

EID: 84867771116     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0042     Document Type: Article

References (33)

1. Ryan JW, Whitaker C, Chin A. Localization of angiotensin converting enzyme (kininase II) immuno-cytochemistry and immunofluorescence. Tissue Cell 1976;8:125-45.
2. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E. Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem 1991;266:5540-6.
3. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987;56:345-8.
4. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-6.
5. Rousseau-Plasse A, Lenfant M, Potier P. Catabolism of the hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin I-converting enzyme N-active site. Bioorg Med Chem 1996;4:1113-9.
6. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med 1975;59:365-72.
7. Turton CW, Grundy E, Firth G, Mitchell D, Rigden BG, Turner-Warwick M. Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax 1979;34:57-62.
8. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002;40:256-65.
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
10. Sharma P, Smith I, Maguire G, Stewart S, Shneerson J, Brown MJ. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997;349:1602-3.
11. Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, Van den Bosch JM, et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Resp Med 2007;101:510-5.
12. Muller BR. Analysis of serum angiotensin-converting enzyme. Ann Clin Biochem 2002;39:436-43.
13. Maguire GA, Price CP. A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum. Ann Clin Biochem 1985;22:204-10.
14. Tanaka C, Kamide K, Takiuchi S, Miwa Y, Yoshi M, Kawano Y, et al. An alternative fast convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003;26:301-6.
15. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res 1992:20:1433.
16. International Federation of Clinical Chemistry, Expert Panel on Theory of Reference Values. Approved recommendation on the theory of reverence values. Part I. The concept of reference values. J Clin Chem Clin Biochem 1987;25:337-42.
17. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987;25:639-44.
18. Part 3. Reparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988;26:593-8.
19. Part 4. Control of analytical variation in the production, transfer and application of reference values. Clin Chim Acta 1991;202:S5-11.
20. Part 5. Statistical treatment of collected reference values: determination of reference limits. J Clin Chem Clin Biochem 1987;25:645-56.
21. Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem 1987;25:657-62.
22. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; proposed guideline, 3rd ed. CLSI document C28-P3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
23. Tukey JW. Exploratory data analysis reading. MA (USA): Addison-Wesley Pub, 1977:688.
24. García-Arumí E, Segura RM, Pascual C, Schwartz S. Determinación de la concentración catalítica de la dipeptidil carboxipeptidasa I por un método continuo. Quím Clín 1988;7:17-20.
25. Sociedad española de Química Clínica. Comitéde garantía de la calidad y acreditación. Base de datos de variación biológica. Available from: htpp://www.seqc.es/es/ Comisiones/7/51/102/. Accessed 19 January 2012.
26. Harris EK. Effects of intra-and inter-individual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
27. Ronca-Testoni S. Direct spectrophotometric assay for angiotensinconverting enzyme in serum. CIin Chem 1983;29:1093-6.
28. Bénéteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC. Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem 1986;32:884-6.
29. Faure-Delanef L, Baudin B, Bénéteau-Burnat B, Beaudoin JC, Giboudeau J, Cohen D. Plasma concentration kinetic constants and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clin Chem 1998;44:2083-7.
30. Biller H, Zissel G, Ruprecht B, Nauck M, Busse-Grawitz A, Müller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 2006;28:1085-90.
31. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
32. Domingues-Montanari S, Parés M, Hernández-Guillamon M, Fernández-Cadenas I, Mendioroz M, Ortega G, et al. The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. Eur J Neurol 2010;17:1390-2.
33. O'Toole L, Stewart M, Padfield P, Charner K. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure. J Cardiovasc Pharmacol 1998;32:988-94.